Expression of DAF in Gastric Cancer and Its Clinical Significance

王芹,张玲,张维东,魏丽,贾青
DOI: https://doi.org/10.3969/j.issn.1673-5269.2008.09.012
2008-01-01
Abstract:OBJECTIVE:To detect the expression of decay-accelerating factor (DAF,CD55) in gastric cancer, and analyze its role in the promotion of tumor cell proliferation,metastasis and the tumor vascular growth, evading from immune surveillance,as well as discuse the relationship between DAF expression and PCNA or VEGF expression.METHODS:Immunohistochemistry was used to detect DAF,PCNA and VEGF expressions of 32 cases of stomach cancer and 20 cases of adjacent tissues case sections.RESULTS:In gastric cancer biopsy specimens,DAF,PCNA and VEGF-positive rates were 78.1%, 75.0% and 65.6% respectively; in adjacent tissues, the positive rates were 25.0%,30.0% and 25.0% respectively, and those in the tumor tissue were significantly higher than those in the adjacent control group,P0.05. DAF expression and gastric cancer pathologic stage Ⅲ,Ⅳ were significantly correlated,P0.05. DAF and PCNA positive rates in the metastasis group were higher than those in the group without metastasis, and DAF and gastric cancer metastasis were relevant.CONCLUSIONS:The high expression of DAF is significantly correlated with gastric cancer clinical stage and metastasis, and can be used as prognostic indicators of reference.
What problem does this paper attempt to address?